⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue Tumors

Official Title: Inzisionelle Negative Drucktherapie Nach Resektion Von Weichteiltumoren - Eine Prospektive, Randomisierte, Kontrollierte Klinische Studie

Study ID: NCT03900078

Study Description

Brief Summary: This study is aimed to examine the value of incisional negative pressure therapy after resection of soft tissue tumors. Its a prospective randomized trial comparing incisional negative pressure to standard wound dressings.

Detailed Description: Wound healing after resection of large soft tissue tumors is often impaired by large dead space and fluid collection, potentially resulting in seroma formation and infection. Aim of the study is to compare negative pressure wound therapy to standard wound dressing in terms of quantity of drainage fluid and wound healing complications.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum, NRW, Germany

Contact Details

Name: Björn Behr, MD

Affiliation: Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum

Role: PRINCIPAL_INVESTIGATOR

Name: Mehran Dadras, MD

Affiliation: Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil Bochum

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: